Related Experiment Video
Updated: Sep 4, 2025

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
Published on: December 22, 2023
Long-term results of sclerotherapy for cervical-thoracic-mediastinal lymphatic and venous malformations: A case
1Department of Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Insights
Sclerotherapy effectively treats rare infant cervical-thoracic-mediastinal lymphatic malformations (LVMs). This minimally invasive approach offers a low-risk, high-cure rate with no long-term developmental side effects.
Area of Science:
- Vascular Surgery
- Pediatric Surgery
- Interventional Radiology
Background:
- Cervical-thoracic-mediastinal lymphatic malformations (LVMs) in infants are rare and challenging to treat due to high risks and recurrence.
- Infantile LVMs can cause severe symptoms like dyspnea and breathing difficulties.
Purpose of the Study:
- To evaluate the efficacy and safety of sclerotherapy for treating complex infant LVMs.
- To compare sclerotherapy with surgical resection for thoracic-mediastinal LVMs.
Main Methods:
- A phased, step-by-step sclerotherapy approach using bleomycin and triamcinolone acetonide.
- Percutaneous catheterization under B-ultrasound guidance for thoracic and mediastinal LVMs.
- Long-term follow-up to assess recurrence and developmental outcomes.
Main Results:
- Complete regression of submandibular and cervical LVMs.
- Approximately 95% regression of thoracic and mediastinal LVMs.
- No recurrence observed during an 11-year follow-up period with normal development.
Conclusions:
- Sclerotherapy is an effective and minimally invasive treatment for infant cervical-thoracic-mediastinal LVMs.
- Sclerotherapy presents a lower risk profile compared to surgical resection, with significant curative effects.
- This treatment demonstrates no adverse effects on infant development.
Abstract:
Cervical-thoracic-mediastinal LVMs in infants is rare, and very difficult to be cured because of life-threatening risk and recurrence. An infant with cervical-thoracic-mediastinal LVMs was treated in our department. Left neck was thick at birth, usually depressed, lazy and inactive. He showed dyspnea after about 3 min of automatic activity, with increased wheezing and open-mouth breathing, squatting after walking no more than 6 steps. There were masses and bulges in the left submandibular area and the left neck. The left cervical root and left clavicle were full. LVMs was diagnosed, and treated by sclerotherapy with bleomycin and triamcinolone acetonidein in a phased and step-by-step manner. The thoracic LVMs and mediastinal LVMs were cannulated under general anesthesia B-ultrasound guidance with an indwelling catheter; drugs were administered via the catheter. After several sessions, the submandibular LVMs and cervical LVMs were completely regressed, the thoracic LVMs and mediastinal LVMs were approximately 95 % regressed. Follow-up of 11 years, there was no recurrence; the lungs, thoraxes, and spines were well developed and free to move. Surgical resection of thoracic-mediastinal LVMs has high life-threatening risk, especially in children, and can't remove all of the LVMs. Comparing with surgical resection, sclerotherapy has the advantages of minimally invasive, low risk, conveniently repeated treatment, obvious curative effect. Therefore, cervical-thoracic-mediastinal LVM in infants can be effectively cured by sclerotherapy; the sclerotherapy has no obvious side effect on the development.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Development of the Lymphatic System
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
Venous Thrombosis IV: Nursing Management

